Skip to content
Late-StageResearch compound

Primobolan (Methenolone)

An anabolic steroid as tablets and injections; the injectable is a medicine in Germany and Spain, banned in competitive sport.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Primobolan (Methenolone) vial

DETAILED OVERVIEW

What is Primobolan (Methenolone)?

Primobolan (Methenolone) is an anabolic steroid, a lab-made hormone with muscle-building effects, and it comes both as a tablet and as an oily injection into the muscle. It was originally made to treat anemia and weakness after severe illness. It was withdrawn from the US drug market long ago, but in Germany and Spain the injectable form is still available as a prescription medicine.

Like testosterone, it acts on muscle, but it does not turn into estrogen and is less of a burden on the liver than most steroids taken by mouth. It can cause acne, faster hair loss in people prone to it and unfavorable cholesterol changes, and it suppresses the body's own testosterone production. In women it can cause a deeper voice, hair growth and menstrual problems, which are partly irreversible. It must not be used in pregnancy or breastfeeding, because it can cause a female baby to develop male traits. It is banned in competitive sport, and without a prescription it is illegal in Hungary and Poland.

Mechanism

AR agonist, 1-methyl-DHT, NOT aromatized

Anabolic:Androgenic

88:44

Half-life

4-6 h (Ac oral), 5-7 d (Enan IM)

Onset

1-2 h (Ac oral), 48-72 h (Enan IM)

Legal status

Bayer Primobolan Depot DE/ES Rx, USA: discontinued

Data console

Lab data

Androgenic:Anabolic88:44
AR bindingModerate AR affinity (~28% vs testosterone in vitro). High…
Active half-life~24 h (depot-driven)
Detection windowUrinary: 4-6 months (extra long, enanthate ester + 1-methyl metabolite family). WADA-accredited GC-MS and LC-MS/MS.
Aromatizationnone
Hepatotoxicityvery-low

Safety

Side effects, stop signs, contraindications

Side effects · 7

  • Androgenic skin and hair effects: methenolone is a DHT structural analog, so it can accelerate hair loss in those genetically prone to androgenetic alopecia, plus acne and oily skin (5-alpha-reductase inhibitors like finasteride do NOT protect, as the molecule is already 5-alpha-reduced).
  • Virilization in women: although methenolone has one of the lowest androgenic potentials among AAS, the risk is NOT zero, higher doses can cause voice deepening, hirsutism, clitoral enlargement and menstrual disruption, some of which is irreversible. Any virilization sign warrants immediate cessation.
  • Adverse lipid profile: HDL cholesterol falls and LDL may rise (roughly 15-25% HDL drop expected during a cycle). The effect can be more sustained with injectable enanthate due to longer cumulative exposure than with the short-half-life oral acetate.
  • HPTA suppression and impaired fertility: methenolone suppresses the hypothalamic-pituitary axis, lowering LH/FSH and thereby endogenous testosterone production and spermatogenesis. Though milder than with testosterone-based steroids, post-cycle therapy (e.g. clomiphene + tamoxifen) is advised in men for recovery.
  • Oral acetate form: hepatotoxicity is low (NOT 17-alpha-alkylated), but because of the very low oral bioavailability (~6%) the high daily dose required (50-100 mg) can cause mild liver enzyme elevation (ALT/AST), so liver panel monitoring is warranted.
  • Injectable enanthate form: the oily IM injection can cause local reactions, post-injection pain (PIP), redness, swelling, and with non-sterile technique a risk of abscess or infection.
  • Prostate stimulation: as a DHT analog, methenolone can stimulate androgen-dependent prostate tissue, potentially worsening prostate enlargement (BPH symptoms) in older men; PSA monitoring is advised above age 30-40.

Contraindications · 7

  • Pregnancy and breastfeeding: methenolone's androgenic action is teratogenic and can virilize a female fetus, absolutely contraindicated during pregnancy and lactation.
  • Prostate or breast carcinoma (in men): in androgen-dependent tumors AAS can promote tumor growth, so known or suspected prostate or male breast cancer is a contraindication.
  • Family history of androgenetic alopecia: as a DHT structural analog it accelerates genetically determined hair loss, which cannot be prevented even by a 5-alpha-reductase inhibitor.
  • Cardiovascular disease or dyslipidemia: due to the HDL-lowering, LDL-raising effect, it should be avoided with pre-existing heart disease, high LDL or uncontrolled hypertension.
  • Significant liver dysfunction (especially the oral acetate form): with pre-existing elevated ALT/AST or active liver disease the high-dose oral form should be avoided; concurrent alcohol and paracetamol increase the burden.
  • Concurrent coumarin-type anticoagulants (e.g. warfarin): AAS can potentiate the anticoagulant effect and bleeding risk, requiring close INR monitoring and dose adjustment.
  • Competitive sport under WADA testing: methenolone is banned year-round (S1.1), and the injectable enanthate's metabolites are detectable in urine for up to 4-6 months, contraindicated for tested athletes.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Primobolan (Methenolone)?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.